Company profile
Ticker
BETRF
Exchange
Website
CEO
Dr. Ahmad Doroudian Ph.D.
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
Neurokine Pharmaceuticals Inc., Pivot Pharmaceuticals Inc.
SEC CIK
BETRF stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
31 Dec 24
6-K
Material Change Report
9 Dec 24
6-K
Material Change Report
15 Oct 24
6-K
Current report (foreign)
26 Sep 24
6-K
Material Change Report
29 Aug 24
6-K
Material Change Report
8 Aug 24
6-K
Material Change Report
15 Jul 24
6-K
Current report (foreign)
27 Jun 24
6-K
Material Change Report
17 Jun 24
20-F
2024 FY
Annual report (foreign)
30 May 24
Latest ownership filings
Financial summary
Quarter (USD) | Jan 24 | Jan 23 | Jan 22 | Jan 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jan 24 | Jan 23 | Jan 22 | Jan 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |